Antinuclear Antibody Test Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 11.3% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 2 billion and is projected to reach USD 6.6 billion by the completion of 2034. Antinuclear Antibody (ANA) Test is a diagnostic procedure which is designed to identify antibodies targeting the body's cell nuclei and reveal potential autoimmune disorders such as lupus or rheumatoid arthritis.
Request for sample : https://www.fatposglobal.com/sample-request/antinuclear-antibody-test-market-1854